These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 18261586

  • 1. Impact of hepatitis serology on development of leukopenia after solid organ transplantation.
    Karakus S, Arin BE, Arat Z, Karakayali H, Haberal M.
    Transplant Proc; 2008; 40(1):199-201. PubMed ID: 18261586
    [Abstract] [Full Text] [Related]

  • 2. Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German data.
    Kliem V, Burg M, Haller H, Suwelack B, Abendroth D, Fritsche L, Fornara P, Pietruck F, Frei U, Donauer J, Lison AE, Michel U.
    Transplant Proc; 2008 May; 40(4):909-14. PubMed ID: 18555076
    [Abstract] [Full Text] [Related]

  • 3. Impact of hepatitis B and C virus infections on kidney transplantation: a single center experience.
    Santos L, Alves R, Macario F, Parada B, Campos M, Mota A.
    Transplant Proc; 2009 Apr; 41(3):880-2. PubMed ID: 19376378
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation.
    Locasciulli A, Bruno B, Alessandrino EP, Meloni G, Arcese W, Bandini G, Cassibba V, Rotoli B, Morra E, Majolino I, Alberti A, Bacigalupo A, Italian Cooperative Group for Blood and Marrow Transplantation.
    Bone Marrow Transplant; 2003 Feb; 31(4):295-300. PubMed ID: 12621466
    [Abstract] [Full Text] [Related]

  • 5. Kidney transplantation from donors with viral B and C hepatitis.
    Veroux P, Veroux M, Sparacino V, Giuffrida G, Puliatti C, Macarone M, Fiamingo P, Cappello D, Gagliano M, Spataro M, Di Mare M, Cannizzaro MA, Severino V.
    Transplant Proc; 2006 May; 38(4):996-8. PubMed ID: 16757242
    [Abstract] [Full Text] [Related]

  • 6. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [Abstract] [Full Text] [Related]

  • 7. Different impacts of hepatitis B virus and hepatitis C virus on the outcome of kidney transplantation.
    Ingsathit A, Thakkinstian A, Kantachuvesiri S, Sumethkul V.
    Transplant Proc; 2007 Jun; 39(5):1424-8. PubMed ID: 17580153
    [Abstract] [Full Text] [Related]

  • 8. Clinical course of hepatitis C virus infection in renal transplant recipients.
    Savas N, Ocal S, Colak T, Karakayali H, Yilmaz U, Haberal M.
    Transplant Proc; 2007 May; 39(4):984-6. PubMed ID: 17524869
    [Abstract] [Full Text] [Related]

  • 9. Impact of hepatitis B and hepatitis C virus infections on patients and allograft outcomes in renal transplant recipients: a single center study.
    Ghafari A, Sanadgol H.
    Transplant Proc; 2008 May; 40(1):196-8. PubMed ID: 18261585
    [Abstract] [Full Text] [Related]

  • 10. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV.
    Minz M, Sharma A, Das A, Chawla Y.
    Transplant Proc; 2008 Sep; 40(7):2386-8. PubMed ID: 18790242
    [Abstract] [Full Text] [Related]

  • 11. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.
    Cuellar-Rodriguez J, Avery RK, Lard M, Budev M, Gordon SM, Shrestha NK, van Duin D, Oethinger M, Mawhorter SD.
    Clin Infect Dis; 2009 Sep 01; 49(5):710-6. PubMed ID: 19635026
    [Abstract] [Full Text] [Related]

  • 12. Impact of human leukocyte antigen matching on hepatitis B virus recurrence after liver transplantation.
    Zhao H, Hu JH, Zhou L, Xu X, Wu J, Meng XQ, Fan J, Ma WH.
    Hepatobiliary Pancreat Dis Int; 2010 Apr 01; 9(2):139-43. PubMed ID: 20382583
    [Abstract] [Full Text] [Related]

  • 13. The role of HBV genotype, core promoter and precore mutations in advanced liver disease in renal transplant recipients.
    Tsai MC, Chen CH, Lee CM, Chen YT, Chien YS, Hung CH, Wang JH, Lu SN, Yen YH, Changchien CS, Hu TH.
    J Hepatol; 2009 Feb 01; 50(2):281-8. PubMed ID: 19070392
    [Abstract] [Full Text] [Related]

  • 14. [Outcome of the kidney transplant recipients with chronic hepatitis B virus].
    Chen ZY, Lai YT, Huang WJ, Cai YQ.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun 01; 31(3):392-5. PubMed ID: 16859131
    [Abstract] [Full Text] [Related]

  • 15. Kidney transplantation from hepatitis B surface antigen-positive donors into hepatitis B surface antigen-positive recipients: preliminary findings.
    Veroux M, Puliatti C, Macarone M, Cappello D, Gagliano M, Spataro M, Di Mare M, Giuffrida G, Veroux P.
    Transplant Proc; 2005 Jun 01; 37(6):2467-8. PubMed ID: 16182711
    [Abstract] [Full Text] [Related]

  • 16. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
    Tateo M, Roque-Afonso AM, Antonini TM, Medja F, Lombes A, Jardel C, Teicher E, Sebagh M, Roche B, Castaing D, Samuel D, Duclos-Vallee JC.
    AIDS; 2009 Jun 01; 23(9):1069-76. PubMed ID: 19417577
    [Abstract] [Full Text] [Related]

  • 17. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
    Yu L, Koepsell T, Manhart L, Ioannou G.
    Liver Transpl; 2009 Oct 01; 15(10):1343-50. PubMed ID: 19790164
    [Abstract] [Full Text] [Related]

  • 18. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep 01; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 19. The influence of hepatitis B and C virus infections on patient and allograft outcomes in kidney transplantation.
    Uyar M, Sahin S, Dheir H, Gurkan A.
    Transplant Proc; 2011 Apr 01; 43(3):850-2. PubMed ID: 21486613
    [Abstract] [Full Text] [Related]

  • 20. The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study.
    Delladetsima I, Psichogiou M, Sypsa V, Psimenou E, Kostakis A, Hatzakis A, Boletis JN.
    Am J Kidney Dis; 2006 Feb 01; 47(2):309-16. PubMed ID: 16431260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.